BOSTON and LONDON, Feb. 10, 2025 /PRNewswire/ — Caldwell, a law firm renowned for its expertise in intellectual property, life sciences, and technology transactions, is pleased to announce its role in advising Eppendorf Group, a leading provider of laboratory equipment, consumables, and services for the life sciences industry, on the successful sale of eLabNext, including U.S. and Canadian assets to SciShield, a U.S.-based company. This transaction has led to the creation of SciSure, a global technology company serving 800+ unique organizations, 550,000+ research and administrative users, and 37,000+ lab groups across Europe, North America, Asia, and Australia. This cross-border transaction, executed in collaboration with Taylor Wessing (Netherlands), reflects Caldwell’s commitment to delivering exceptional legal support in complex and high-profile matters.
The transaction highlights Caldwell’s depth in M&A, life sciences, and technology, showcasing the firm’s ability to provide comprehensive, multi-jurisdictional support. Caldwell’s team, led by Partner Marcus Wolter and Associates Daniel O’Brien and Bianca Lindau, worked seamlessly with Taylor Wessing’s Marnix Geraerts and other key legal advisors to achieve this milestone.
The transaction was led from the client side by Dr. Julien Schlagowski, LL.M. (Stellenbosch), Legal Counsel at Eppendorf Group, and Klaus Ferber, Senior Vice President, Global Digital & Channel Business at Eppendorf Group, supported also by Dr. Catherina Lodemann, Senior Vice President, Legal, IP & Compliance at Eppendorf Group.
On buy-side, legal support was provided by Thomas Queen (QS+S), and Tobias Miedema, Max de Vreede, and Diederick de Boer (Lexence).
“This transaction underscores Caldwell’s ability to navigate the intricacies of cross-border M&A in the life sciences and technology sectors,” said Marcus Wolter, Partner at Caldwell. “We are proud to have partnered with Eppendorf and our esteemed colleagues at Taylor Wessing to deliver this successful outcome.”
Caldwell congratulates Eppendorf, SciShield and all involved parties on this significant achievement.
About Caldwell
Caldwell is a law firm specializing in intellectual property, M&A, and corporate legal services for high-growth companies, venture capital funds, and established corporates. With offices in Boston, Los Angeles, and London, Caldwell delivers innovative legal solutions across industries, including life sciences, technology, and healthcare.
Media Contact:
Mona Lucier
Director of Marketing
Caldwell
Email: mona@caldwelllaw.com
Phone: (857) 496-8913
SOURCE Caldwell
The ItovebiTM (inavolisib)-based regimen reduced the risk of death by more than 30% in people…
Libtayo demonstrated a 68% reduction in the risk of disease recurrence or death, the primary…
Pivotal Phase 3 VERITAC-2 clinical trial results presented at ASCO demonstrate 2.9-month improvement in median…
Reflex blood-based multi-cancer early detection (MCED) test demonstrated clinically meaningful per-cancer Positive Predictive Value (PPV)…
26% preliminary objective response rate observed in heavily pre-treated patients with metastatic microsatellite stable colorectal…
– Complete response (CR) observed in 73% (27/37) of evaluable patients with low-grade upper tract urothelial…
![](data:image/svg+xml;charset=utf-8,<svg height="32px" width="32px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
![](data:image/svg+xml;charset=utf-8,<svg height="72px" width="400px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
![](data:image/svg+xml;charset=utf-8,<svg height="12px" width="12px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
![](data:image/svg+xml;charset=utf-8,<svg height="400px" width="1000px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
